drugset / Trial / NCT02856750

Efficacy of Gabapentin vs. Placebo for Adjuvant Pain Control Following Acute Rib Fractures

NCT02856750

RandomizedParallel-groupTriple-blindTreatment

Summary

A Multi-center, Randomized Controlled Trial of the Efficacy of Gabapentin vs. Placebo for Adjutant Pain Control Following Acute Rib Fractures.

Timeline

Start
2016-10
Primary completion
2018-10-23
Completion
2018-10-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 300 mg

Indications

No indication recorded.